MétaCan
Menu
Back to cohort

Use of complementary medicine (CAM) among women receiving chemotherapy for ovarian cancer: A comparison of attitudes between two patient populations

2009· article· en· W2281237368 on OpenAlexaffabout
L. Helpman Bek, Sarah E. Ferguson, Melanie Mackean, Lisa W. Le, Andrew Rogerson, A. Dewan, Helen Mackay

Bibliographic record

VenueJournal of Clinical Oncology · 2009
Typearticle
Languageen
FieldMedicine
TopicComplementary and Alternative Medicine Studies
Canadian institutionsPrincess Margaret Cancer CentreUniversity of Toronto
Fundersnot available
KeywordsMedicineCancerInternal medicineOvarian cancerFamily medicineTraditional medicine

Abstract

fetched live from OpenAlex

e20545 Background: CAM use in cancer patients (pts) is common. The aim of this study was to compare patterns of CAM use and attitudes to CAM among ovarian cancer (EOC) pts in Canada and Scotland. Methods: Patients receiving chemotherapy for EOC in Princess Margaret Hospital (PMH), Toronto and the Edinburgh Cancer Centre (ECC), Scotland, completed a survey on CAM taken within the previous month as well as a questionnaire assessing patient attitudes and perceptions of CAM. A comparison between the 2 patient populations and between CAM users and non-users was made. Results: 194 pts (100 ECC: 94 PMH) were enrolled on study. The use of CAM in PMH was significantly higher than in ECC (52% vs. 36%, p=0.02). Whilst both populations thought it important for their oncologist to be aware of CAM usage (86% PMH: 93% ECC), pts from PMH were less likely to inform their compared to pts from ECC (50% vs 81%, p=0.02). Patterns of CAM use differed between the 2 populations: Multivitamins were the most common CAM in both populations (31% PMH:13% ECC). They were not considered CAM for the purpose of analysis. Most commonly used CAM in PMH were Soy products (12%), vitamin C (10%) and Green Tea (9%); in ECC pts used Omega 3 and fish oil (9%), Evening Primrose (7%) and vitamin C (6%). Although the majority of CAM users in both populations found CAM to be helpful (57% PMH: 61% ECC) only a minority thought they would cure their cancer (18% PMH: 6% ECC), prevent its spread (31% PMH: 14% ECC) or prevent a recurrence (20% PMH: 11% ECC). Users more often felt CAM relieved symptoms (45% PMH: 42% ECC), boosted the immune system (55% PMH: 56% ECC) or improved their quality of life (43% PMH: 53% ECC). ECC CAM users were more likely than PMH users to concede that CAMs have side effects (39% vs 29%) or could impact the efficacy of conventional treatment (17% vs 6%). CAM users were more likely than non-users to agree with positive statements and to disagree with negative statements about CAM. Conclusions: CAM use is common among pts receiving chemotherapy for EOC. CAM use was more prevalent among North American pts than Scottish pts. Attitudes and patterns of CAM usage differ and are culturally sensitive. Oncologists need to be aware of this when initiating discussion about CAM with their patients during cancer treatment. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.032
Threshold uncertainty score0.063

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.464
GPT teacher head0.585
Teacher spread0.121 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2009
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicComplementary and Alternative Medicine StudiesFrench-language works237,207